Know Cancer

or
forgot password
  • cancer clinical trials in temple, TX

  • Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
    CCOP - Scott and White Hospital
    Temple, Texas 76508
    Neuroblastoma
    Safety Study of Imexon Treatment of Patients With Metastatic or Disseminated Malignancy
    Investigational Site 014
    Temple, Texas 76508
    Neoplasm Metastasis
    Stress Management Therapy in Patients Receiving Chemotherapy for Cancer
    CCOP - Scott and White Hospital

    Trial Locations
    CCOP - Scott and White Hospital
    Scott and White Cancer Institute
    Psychosocial Effects of Cancer and Its Treatment, Unspecified Adult Solid Tumor, Protocol Specific
    Phase II Trial Evaluating the Efficacy and Tolerability of Aprepitant & Palonosetron for Prevention of Chemotherapy-Induced Nausea and Vomiting
    Texas A & M university / Scott and White Clinic
    Temple, Texas 76508
    Colorectal Cancer, Nausea and Vomiting
    Safety and Efficacy of Atiprimod Treatment for Patients With Low to Intermediate Grade Neuroendocrine Carcinoma
    Scott and White Memorial Hospital, Scott Sherwood and Brindley Facility
    Temple, Texas 76508
    Neuroendocrine Carcinoma
    Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers
    CCOP - Scott and White Hospital
    Temple, Texas 76508
    Colorectal Cancer, Fatigue, Long-term Effects Secondary to Cancer Therapy in Adults, Pain, Psychosocial Effects of Cancer and Its Treatment
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    CCOP - Scott and White Hospital
    Temple, Texas 76508
    Leukemia
    Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer
    Sanofi-Aventis Investigational Site Number 840064
    Temple, Texas 76508
    Urinary Bladder Neoplasms
    Phase 1 Study of MDX-1401 in Patients With CD30-positive Refractory/Relapsed Hodgkin's Lymphoma
    Scott and White Memorial Hospital and Clinic
    Temple, Texas
    Hodgkin's Lymphomas
    A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
    Scott and White Hospital and Clinics
    Temple, Texas 76508
    Pancreatic Neoplasms
    Cognition in the Study of Tamoxifen and Raloxifene
    Scott and White Hospital
    Temple, Texas 76508
    Cognition, Aging
    An Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian Cancer
    Scott & White Memorial Hospital and Clinic
    Temple, Texas 76508
    Ovarian Cancer
    A Phase 1-2, Multicenter, Open-Label Study of AEG35156 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia and Indolent B-Cell Lymphomas
    Scott and White Memorial Hospital
    Temple, Texas 76508
    Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell
    S0309, Collecting and Storing Blood and Bone Marrow Samples From Patients With Myeloma, Waldenstrom's Macroglobulinemia, Amyloidosis, or Monoclonal Gammopathy of Undetermined Significance
    CCOP - Scott and White Hospital
    Temple, Texas 76508
    Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Precancerous Condition
    Hernia Repair in Multiply Morbid Patients
    Scott & White Medical Center
    Temple, Texas 76508
    Ventral Hernia
    Carboplatin and Paclitaxel Combined With Cetuximab and/or Cixutumumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Scott and White Memorial Hospital
    Temple, Texas 76508
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    A Multicenter, Open-Label, Single-Arm Evaluation of Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Who Have Experienced CINV(Chemotherapy-Induced Nausea and Vomiting) During the Previous Cycle of Low Emetogenic Chemotherapy (LEC)
    Scott and White Memorial Hospital
    Temple, Texas 76508
    Patients With Confirmed Malignant Disease to Receive Low Emetogenic Chemotherapy (LEC) or Who Experienced at Least Nausea and Vomiting During Last Cycle of LEC
    Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer
    Scott & White Healthcare
    Temple, Texas 76508
    Locally Recurrent or Metastatic Breast Cancer
    Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer
    Scott and White Memorial Hospital
    Temple, Texas 76508
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Small Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer, Stage IVB Cervical Cancer
    Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
    Vasicek Cancer Center at Scott & White Memorial Hospital
    Temple, Texas 76508
    Metastatic Pancreatic Cancer
    Effectiveness of Electronic Health Record-Based Interventions for Improving Follow-Up in Primary Care
    Scott and White Memorial Hospital
    Temple, Texas 76508
    Colon Cancer, Lung Cancer, Prostate Cancer
    Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma
    Scott and White Memorial Hospital
    Temple, Texas 76508
    Childhood Alveolar Soft-part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, Childhood Fibrosarcoma, Childhood Gliosarcoma, Childhood Leiomyosarcoma, Childhood Liposarcoma, Childhood Neurofibrosarcoma, Childhood Synovial Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Osteosarcoma
    Safety and Effectiveness Study of CPI-613 and/or Gemcitabine to Treat Metastatic Pancreatic Cancer
    Temple Vasicek Cancer Treatment Center
    Temple, Texas 76508
    Metastatic Pancreatic Adenocarcinoma